Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management [Yahoo! Finance]
Quest Diagnostics Incorporated (DGX)
Last quest diagnostics incorporated earnings: 4/22 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
ir.questdiagnostics.com
Company Research
Source: Yahoo! Finance
VANCOUVER, British Columbia, November 15, 2024 BUSINESS WIRE Augurex Life Sciences Corp ., a leader in autoimmune biomarker-based diagnostics, today announced that it has formed a nonexclusive agreement with Quest Diagnostics, a leading provider of diagnostic information services, under which Quest will validate and offer a lab-developed test based on the Augurex 14-3-3? (eta) biomarker in the United States. Quest intends to begin offering the test service to physicians from its advanced laboratory in San Juan Capistrano, Calif., by December 2, 2024. With a physician's order, patients interested in the test will be able to provide a blood specimen at one of over 2,000 Quest Diagnostics patient service centers in the United States. The 14-3-3eta test aids in detecting elevated levels of the 14-3-3eta protein, which are specific for rheumatoid arthritis (RA) and linked to more severe disease and joint damage risk. "Reintroducing the 14-3-3eta test with Quest Diagnostics is an imp
Show less
Read more
Impact Snapshot
Event Time:
DGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DGX alerts
High impacting Quest Diagnostics Incorporated news events
Weekly update
A roundup of the hottest topics
DGX
News
- $6.1 Bn Dietary Supplement Testing Services Global Market Opportunities and Strategies to 2033: Contaminant Testing Platforms, Adulteration Panel Analysis, AI-Driven Platforms for Improved Testing [Yahoo! Finance]Yahoo! Finance
- Quest Diagnostics (DGX) Up 2.7% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]Yahoo! Finance
- Neuron23 Unveils Groundbreaking Phase 2 Trial in Early Parkinson's Disease [Yahoo! Finance]Yahoo! Finance
- Quest Diagnostics Incorporated (NYSE: DGX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Vitamin D Testing Market Size to Reach USD 1774.70 Million by 2031 | SkyQuest Technology [Yahoo! Finance]Yahoo! Finance
DGX
Earnings
- 10/22/24 - Beat
DGX
Sec Filings
- 11/7/24 - Form 4
- 10/30/24 - Form 4
- 10/28/24 - Form 144
- DGX's page on the SEC website